AbbVie, Inc. is a company in the U.S. stock market and it is a holding in 252 U.S.-traded ETFs. ABBV has around 125.1M shares in the U.S. ETF market. The largest ETF holder of ABBV is the SPDR S&P 500 ETF Trust (SPY), with approximately 18.56M shares. Investors may also find of interest that the ETF with the largest allocation to ABBV stock is First Trust Nasdaq Pharmaceuticals ETF (FTXH), with a portfolio weight of 7.97%. On average, U.S. ETFs allocate 1.13% of ABBV to their portfolios.
Additionally, ABBV is a favorite stock for Multi-factor and Vanilla ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ABBV as a holding is the Direxion Daily S&P Biotech Bull 3X Shares (LABU), with a return of 109.92%.